Q4 2023 · 13F-HR
Patient Square Capital LPholdings as filed
Filed 2024-02-13 · accession 0000950123-24-001861
$182.9M
Reported value
2
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $141.9M | 77.6% | 12,639,920 | Common | SOLE |
| 270087208 | — | EARGO INC | $41.0M | 22.4% | 15,821,299 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.